It is a pharma private limited company based in Gurgaon Haryana, Haryana, India, established in 1962.
1962 | Gurgaon Haryana, Haryana, India | ActiveMeditex Pharma Pvt Ltd, a active private limited company, was established on 23 January 1962 in Gurgaon Haryana, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239HR1962PTC002419. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Kasi Vishwanathan Sundaram (Director), Suresh Sundram (Director), Sunil Sundaram (Director). Past directors included Sunil Sundaram. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B 232Industrial Estate Mehrauli Road, Gurgaon Haryana, Haryana.
U24239HR1962PTC002419
002419
23 January 1962
₹2.50 M
₹2.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Meditex Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kasi Vishwanathan Sundaram | Director | 13 May 1967 | Current |
| Suresh Sundram | Director | 01 Sep 1997 | Current |
| Sunil Sundaram | Director | 25 Mar 2017 | Current |
| Jaya Sundaram | Director | 01 Sep 1997 | Current |
| Kasi Viswanathan Krishnan | Director | 01 Dec 1979 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Meditex Pharma Pvt Ltd, for the financial year ended 2016, experienced Minor drop in revenue, with a 0.56% decrease. The company also saw a slight decrease in profitability, with a 9.77% decrease in profit. The company's net worth Soared by an impressive increase of 10.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Meditex Pharma had a promoter holding of 93.82% and a public holding of 6.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Meditex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Meditex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Meditex Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Meditex Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Sunil Sundaram was appointed as a Director was appointed as a Director on 25 Mar 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.
Suresh Sundram was appointed as a Director was appointed as a Director on 01 Sep 1997 & has been associated with this company since 28 years 3 months . was recorded as a recent event.
The activity Jaya Sundaram was appointed as a Director was appointed as a Director on 01 Sep 1997 & has been associated with this company since 28 years 3 months . was completed.
Kasi Viswanathan Krishnan was appointed as a Director was appointed as a Director on 01 Dec 1979 & has been associated with this company since 46 years 4 days . was recorded as a recent event.
The CIN of Meditex Pharma Pvt Ltd is U24239HR1962PTC002419.
Meditex Pharma Pvt Ltd is headquartered at B 232Industrial Estate Mehrauli Road, Gurgaon Haryana, Haryana.
Meditex Pharma Pvt Ltd was incorporated on 23 January 1962.
The current directors of Meditex Pharma Pvt Ltd are
The primary industry of Meditex Pharma Pvt Ltd is Trade.
Meditex Pharma Pvt Ltd is unlisted.
The authorized capital of Meditex Pharma Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of Meditex Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX